Fmoc-Lys(Boc)-OH Cas:71989-26-9
| Catalogue Number | XD91503 |
| Product Name | Fmoc-Lys(Boc)-OH |
| CAS | 71989-26-9 |
| Formulae hypotheticaela | C26H32N2O6 |
| M. Pondus | 468.54 |
| Repono Details | Ambiens |
| Tariff Code harmonized | 2924299090 |
Product Specification
| Aspectus | albus ut lux flavo crystal powde |
| Assay | 99% min |
| Liquescens punctum | 130-135 °F (dec.). |
| alpha | -12 (c=2,DMF 24 C) |
| Ferveret | 570.69°C (aestimatio aspera) |
| density | 1.2301 (aestimatio aspera) |
| refractivus index | -12 ° (C=I, DMF) |
| pka | 3.88 ± 0.21 (Predicta) |
| optical operatio | [α]20/D 12±1°, c = 1% in DMF |
| Aqua Solubility | Leviter solutum in aqua. |
| Stabilitas: | Stabulum.Agentibus oxidizing fortis repugnat. |
Utitur - Praeparare dimericam RGD peptide-paclitaxel coniugatam ad exemplar ad integrino-iaculatorum medicamentorum traditionis.Adhibetur etiam ad synthesim DOTA-conjugata multivalentes cyclici-RGD peptidis dendrimeri ad usum tumoris nisi et imaginandi.
Usus ：Fmoc-Lys(Boc)-OH adhiberi potest pro:Solutissima periodo synthesis dihydroimidazolylbutyli dihydroimidazol-3-ium salibus coitu cum resin-p-methylbenzhydrylamine (MBHA). , filo intercalator. Synthesis verborum ε-Boc-ε- (3,5-bis-trifluoromethyl-benzyl) -α-Fmoc-L-Lysine adhibenda est pro 19F NMR sub instrumento protegendo.
Close
